131
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Pre-procedural elevated cardiac troponin predict risk of long-term all-cause mortality after transcatheter aortic valve replacement: a meta-analysis of prospective studies

, , &
Pages 164-170 | Received 20 Aug 2019, Accepted 06 Jan 2020, Published online: 24 Jan 2020

References

  • Ahmed, A.N., et al., 2014. Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis. Annals of medicine, 46 (8), 653–663.
  • Akodad, M., et al., 2019. Prognostic impact of pre-transcatheter and post-transcatheter aortic valve intervention troponin: a large cohort study. Journal of the American Heart Association, 8 (6), e011111.
  • Baldenhofer, G., et al., 2017. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI). Clinical chemistry and laboratory medicine, 55 (2), 275–283.
  • Chorianopoulos, E., et al., 2014. Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis. Clinical research in cardiology, 103 (1), 65–72.
  • Cribier, A., et al., 2006. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Journal of the American college of cardiology, 47 (6), 1214–1223.
  • DerSimonian, R. and Laird, N., 1986. Meta-analysis in clinical trials. Controlled clinical trials, 7 (3), 177–188.
  • Egger, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315 (7109), 629–634.
  • Frank, D., et al., 2013. Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI). International journal of cardiology, 169 (3), e38–e39.
  • Heresi, G.A., et al., 2012. Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension. European respiratory journal, 39 (4), 939–944.
  • Higgins, J.P. and Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21 (11), 1539–1558.
  • Januzzi, J.L., Jr., et al., 2012. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. European heart journal, 33 (18), 2265–2271.
  • Kappetein, A.P., et al., 2012. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Journal of the American college of cardiology, 60 (15), 1438–1454.
  • Khan, N.A., et al., 2005. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation, 112 (20), 3088–3096.
  • Kim, J.B., et al., 2017. GDF-15 (Growth Differentiation Factor 15) is associated with lack of ventricular recovery and mortality after transcatheter aortic valve replacement. Circulation: cardiovascular interventions, 10 (12), e005594.
  • Kociol, R.D., et al., 2010. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. Journal of the American college of cardiology, 56 (14), 1071–1078.
  • Kofler, M., et al., 2017. Prognostic implications of pre-procedural high-sensitivity cardiac troponin T in patients undergoing transcatheter aortic valve replacement. Jacc: cardiovascular interventions, 10 (22), 2345–2346.
  • Kohler, W.M., et al., 2016. Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantation. Cardiovascular therapy, 34, 385–396.
  • Ky, B., et al., 2014. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. Journal of the American college of cardiology, 63 (8), 809–816.
  • Leon, M.B., et al., 2010. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England journal of medicine, 363 (17), 1597–1607.
  • Leon, M.B., et al., 2016. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. New England journal of medicine, 374 (17), 1609–1620.
  • Li, Y., et al., 2019. Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose-response meta-analysis of prospective studies. Biomarkers, 24 (6), 556–565.
  • Ma, L. and Zhao, S., 2017. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. International journal of cardiology, 238, 151–158.
  • Miller, W.L., et al., 2006. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. European heart journal, 27 (9), 1061–1069.
  • Nagarajan, V., et al., 2012. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart, 98 (24), 1778–1786.
  • Navarese, E.P., et al., 2019. Age-related 2-year mortality after transcatheter aortic valve replacement: the YOUNG TAVR registry. Mayo clinic proceedings, 94 (8), 1457–1466.
  • Nishimura, R.A., et al., 2014. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American college of cardiology, 63 (22), 2438–2488.
  • Nishimura, R.A., et al., 2017. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Journal of the American college of cardiology, 70 (2), 252–289.
  • Omland, T., et al., 2009. A sensitive cardiac troponin T assay in stable coronary artery disease. New England journal of medicine, 361 (26), 2538–2547.
  • Paradis, J.M., et al., 2017. Impact of coronary artery disease severity assessed with the SYNTAX score on outcomes following transcatheter aortic valve replacement. Journal of the American heart association, 6 (2), e005070.
  • Parmar, M.K., et al., 1998. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in medicine, 17 (24), 2815–2834.
  • Peters, J.L., et al., 2007. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Statistics in medicine, 26 (25), 4544–4562.
  • Roy, A.K., et al., 2014. Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes. Journal of cardiac failure, 20 (1), 31–37.
  • Sankaramangalam, K., et al., 2017. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. Journal of the American heart association, 6 (10), e006092.
  • Seiffert, M., et al., 2014. Development of a risk score for outcome after transcatheter aortic valve implantation. Clinical research in cardiology, 103 (8), 631–640.
  • Shamekhi, J., et al., 2017. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. International journal of cardiology, 245, 215–221.
  • Smith, C.R., et al., 2011. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England journal of medicine, 364 (23), 2187–2198.
  • Stefanini, G.G., et al., 2014. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. European heart journal, 35 (37), 2530–2540.
  • Stroup, D.F., 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283 (15), 2008–2012.
  • Thygesen, K., et al.; ESC Scientific Document Group, 2019. Fourth universal definition of myocardial infarction (2018). European heart journal, 40 (3), 237–269.
  • Torbicki, A., et al., 2003. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation, 108 (7), 844–848.
  • Vrsalovic, M., 2016. Prognostic effect of cardiac troponin elevation in acute aortic dissection: a meta-analysis. International journal of cardiology, 214, 277–278.
  • Weil, B.R., et al., 2018. Troponin release and reversible left ventricular dysfunction after transient pressure overload. Journal of the American college of cardiology, 71 (25), 2906–2916.
  • Willeit, P., et al., 2017. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. Journal of the American college of cardiology, 70 (5), 558–568.
  • Witberg, G., et al., 2017. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC cardiovascular interventions, 10 (14), 1428–1435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.